Published in J Virol on August 23, 2006
Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10
Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathog (2009) 3.09
Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol (2010) 2.98
Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol (2007) 2.12
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis (2008) 2.08
The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques. Mol Ther (2009) 2.08
Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis (2007) 1.86
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med (2010) 1.76
Dengue virus evolution and virulence models. Clin Infect Dis (2007) 1.64
Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology (2008) 1.60
Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol (2010) 1.45
Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog (2012) 1.44
c-Src protein kinase inhibitors block assembly and maturation of dengue virus. Proc Natl Acad Sci U S A (2007) 1.42
Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42
Dengue viruses - an overview. Infect Ecol Epidemiol (2013) 1.40
The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology (2008) 1.31
Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. J Virol (2010) 1.31
A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog (2009) 1.27
Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One (2011) 1.20
Current progress in dengue vaccines. J Biomed Sci (2013) 1.16
Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. J Virol (2011) 1.16
High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. J Virol (2011) 1.14
Dengue: where are we today? Malays J Med Sci (2009) 1.10
Transcriptomic profiling of diverse Aedes aegypti strains reveals increased basal-level immune activation in dengue virus-refractory populations and identifies novel virus-vector molecular interactions. PLoS Negl Trop Dis (2013) 1.10
Dengue virus and autophagy. Viruses (2011) 1.10
DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis (2011) 1.09
Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis (2008) 1.06
IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. PLoS Negl Trop Dis (2011) 1.06
Understanding the dengue viruses and progress towards their control. Biomed Res Int (2013) 1.02
N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology (2011) 1.02
The polypyrimidine tract-binding protein is required for efficient dengue virus propagation and associates with the viral replication machinery. J Biol Chem (2009) 1.01
Emerging role of lipid droplets in host/pathogen interactions. J Biol Chem (2011) 1.00
Mosquito immunity against arboviruses. Viruses (2014) 0.99
Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. J Neurovirol (2014) 0.98
Dengue virus receptor. Trop Med Health (2011) 0.95
Inhibition of dengue virus entry and multiplication into monocytes using RNA interference. PLoS Negl Trop Dis (2011) 0.94
A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection. PLoS Negl Trop Dis (2012) 0.94
Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice. PLoS One (2010) 0.94
A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology (2012) 0.94
A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice. PLoS One (2012) 0.94
Dengue virus infection: current concepts in immune mechanisms and lessons from murine models. Immunology (2014) 0.92
Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. J Virol (2011) 0.91
The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response. Sci Rep (2014) 0.91
Evolution of dengue virus type 3 genotype III in Venezuela: diversification, rates and population dynamics. Virol J (2010) 0.91
Suppressing dengue-2 infection by chemical inhibition of Aedes aegypti host factors. PLoS Negl Trop Dis (2014) 0.90
Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology (2010) 0.89
An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci (2013) 0.89
Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection. Cytokine Growth Factor Rev (2014) 0.86
Prolonged co-circulation of two distinct Dengue virus Type 3 lineages in the hyperendemic area of Medellin, Colombia. Am J Trop Med Hyg (2010) 0.86
Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico. Am J Trop Med Hyg (2013) 0.85
High affinity human antibody fragments to dengue virus non-structural protein 3. PLoS Negl Trop Dis (2010) 0.85
Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns. BMC Mol Biol (2010) 0.84
RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells. PLoS One (2012) 0.84
Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS. J Virol (2016) 0.83
Effective suppression of dengue virus using a novel group-I intron that induces apoptotic cell death upon infection through conditional expression of the Bax C-terminal domain. Virol J (2014) 0.83
Distribution of fitness in populations of dengue viruses. PLoS One (2014) 0.83
Can't RIDD off viruses. Front Microbiol (2014) 0.83
Dengue virus markers of virulence and pathogenicity. Future Virol (2009) 0.83
A heterocyclic molecule with significant activity against dengue virus. Bioorg Med Chem Lett (2009) 0.82
A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes. PLoS Pathog (2015) 0.82
Dengue virus 2 American-Asian genotype identified during the 2006/2007 outbreak in Piauí, Brazil reveals a Caribbean route of introduction and dissemination of dengue virus in Brazil. PLoS One (2014) 0.81
Construction and characterisation of a complete reverse genetics system of dengue virus type 3. Mem Inst Oswaldo Cruz (2013) 0.81
The relevance of dengue virus genotypes surveillance at country level before vaccine approval. Hum Vaccin Immunother (2014) 0.80
The Zika Pandemic - A Perfect Storm? PLoS Negl Trop Dis (2016) 0.80
Identification of a cryptic prokaryotic promoter within the cDNA encoding the 5' end of dengue virus RNA genome. PLoS One (2011) 0.80
Widespread signatures of local mRNA folding structure selection in four Dengue virus serotypes. BMC Genomics (2015) 0.79
SUMO Modification Stabilizes Dengue Virus Nonstructural Protein 5 To Support Virus Replication. J Virol (2016) 0.79
Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS Negl Trop Dis (2014) 0.79
Neurological manifestations of Zika virus infection. World J Virol (2016) 0.78
Recombinant production of the amino terminal cytoplasmic region of dengue virus non-structural protein 4A for structural studies. PLoS One (2014) 0.78
RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response. PLoS One (2012) 0.78
Carbohydrate-related inhibitors of dengue virus entry. Viruses (2013) 0.78
Genetic variation in the 3' untranslated region of dengue virus serotype 3 strains isolated from mosquitoes and humans in Brazil. Virol J (2013) 0.78
Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication. PLoS Pathog (2016) 0.77
Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci (2013) 0.77
Primary dengue virus infections induce differential cytokine production in Mexican patients. Mem Inst Oswaldo Cruz (2016) 0.77
Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice. Med Microbiol Immunol (2014) 0.76
Dengue Patients with Early Hemorrhagic Manifestations Lose Coordinate Expression of the Anti-Inflammatory Cytokine IL-10 with the Inflammatory Cytokines IL-6 and IL-8. Am J Trop Med Hyg (2016) 0.76
Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients. Am J Trop Med Hyg (2015) 0.76
Zika virus outbreak: an overview of the experimental therapeutics and treatment. Virusdisease (2016) 0.76
Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue. BMC Infect Dis (2015) 0.76
Involvement of Tetraspanin C189 in Cell-to-Cell Spreading of the Dengue Virus in C6/36 Cells. PLoS Negl Trop Dis (2015) 0.76
Experimental inoculation of Artibeus jamaicensis bats with dengue virus serotypes 1 or 4 showed no evidence of sustained replication. Am J Trop Med Hyg (2014) 0.75
Suppression of the Arboviruses Dengue and Chikungunya Using a Dual-Acting Group-I Intron Coupled with Conditional Expression of the Bax C-Terminal Domain. PLoS One (2015) 0.75
A novel dengue virus detection method that couples DNAzyme and gold nanoparticle approaches. Virol J (2013) 0.75
Elevated levels of vascular endothelial growth factor in adults with severe dengue infection. Virusdisease (2016) 0.75
PTB binds to the 3' untranslated region of the human astrovirus type 8: a possible role in viral replication. PLoS One (2014) 0.75
P-TEFb goes viral. Inside Cell (2015) 0.75
Comparative evaluation of permissiveness to dengue virus serotype 2 infection in primary rodent macrophages. J Trop Med (2012) 0.75
Sequence diversity of dengue virus type 2 in brain and thymus of infected interferon receptor ko mice: implications for dengue virulence. Virol J (2016) 0.75
Development and evaluation of an enzyme-linked immunosorbent assay for dengue capsid. Open Virol J (2012) 0.75
Genomic approaches for understanding dengue: insights from the virus, vector, and host. Genome Biol (2016) 0.75
Involvement of fatty acid synthase in dengue virus infection. Virol J (2017) 0.75
CRM1 Inhibitors for Antiviral Therapy. Front Microbiol (2017) 0.75
Gene Drive for Mosquito Control: Where Did It Come from and Where Are We Headed? Int J Environ Res Public Health (2017) 0.75
Garlic Organosulfur Compounds Reduce Inflammation and Oxidative Stress during Dengue Virus Infection. Viruses (2017) 0.75
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
RNA virus mutations and fitness for survival. Annu Rev Microbiol (1997) 10.06
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A (2003) 7.76
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med (1997) 6.57
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med (2003) 6.25
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol (1984) 5.62
RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A (2001) 5.21
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09
Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A (2003) 5.05
A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02
Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res (2003) 4.90
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg (2003) 4.75
High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis (2002) 4.69
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med (2003) 4.69
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis (2002) 4.67
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol (1991) 4.63
Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39
Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg (2001) 4.32
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet (1999) 3.97
An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J (2002) 3.87
Risk factors in dengue shock syndrome. Am J Trop Med Hyg (1997) 3.83
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis (2004) 3.81
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis (2002) 3.77
The WHO dengue classification and case definitions: time for a reassessment. Lancet (2006) 3.69
Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis (2004) 3.68
Structures of immature flavivirus particles. EMBO J (2003) 3.62
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol (1987) 3.30
Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep (2003) 3.29
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol (2005) 3.18
Severe dengue: the need for new case definitions. Lancet Infect Dis (2006) 3.17
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J Biol Chem (1995) 2.93
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis (2006) 2.82
Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis (2005) 2.78
Immunopathogenesis of dengue virus infection. J Biomed Sci (2001) 2.76
Dengue: defining protective versus pathologic immunity. J Clin Invest (2004) 2.73
Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology (1996) 2.71
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol (2004) 2.64
2. Cytokines and chemokines. J Allergy Clin Immunol (2003) 2.54
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg (2005) 2.49
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol (2005) 2.48
Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science (2006) 2.43
Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis (2004) 2.43
Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg (2006) 2.39
Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol (2005) 2.37
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg (2001) 2.35
Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology (1993) 2.34
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol (1999) 2.34
Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg (2004) 2.33
A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet (2005) 2.31
A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3'-end of exogenous viral RNA templates requires 5'- and 3'-terminal complementary sequence motifs of the viral RNA. J Biol Chem (1999) 2.28
Analysis of the steps involved in Dengue virus entry into host cells. Virology (1999) 2.22
Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology (2005) 2.21
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Antigenic structure of flavivirus proteins. Adv Virus Res (2003) 2.15
Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell (2006) 2.08
Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg (1987) 2.07
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol (1998) 2.03
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol (2006) 2.02
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem (2005) 2.02
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol (2000) 2.02
In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5'- and 3'-terminal regions that influence RNA structure. J Biol Chem (2001) 1.97
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
The future of dengue vaccines. Lancet (2002) 1.90
Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol (2004) 1.85
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol (2005) 1.83
Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol (1988) 1.83
Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res (2006) 1.83
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82
Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology (2002) 1.81
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79
High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology (2003) 1.79
Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol (2005) 1.79
IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol (2004) 1.77
Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica (2002) 1.75
Global spread and persistence of dengue. Annu Rev Microbiol (2008) 6.44
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
The WHO dengue classification and case definitions: time for a reassessment. Lancet (2006) 3.69
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe (2010) 3.48
Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog (2010) 3.16
Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg (2005) 3.12
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis (2010) 2.80
High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health (2006) 2.67
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog (2010) 2.62
Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg (2005) 2.49
Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg (2006) 2.39
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis (2010) 2.33
Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol (2010) 2.31
Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med (2011) 2.29
Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis (2011) 2.26
Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol (2003) 2.22
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol (2010) 2.14
The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol (2009) 2.14
Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol (2008) 2.10
Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg (2009) 1.87
Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology (2002) 1.81
Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol (2005) 1.79
Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis (2007) 1.71
High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis (2010) 1.70
Integration of information technologies in clinical studies in Nicaragua. PLoS Med (2007) 1.69
A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis. J Immunol Methods (2006) 1.69
Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology (2004) 1.61
Animal models of dengue virus infection. Viruses (2012) 1.60
Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis (2013) 1.57
Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis (2009) 1.55
Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. Virology (2005) 1.55
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54
Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe (2010) 1.53
Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl Trop Dis (2012) 1.52
Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis (2013) 1.51
Quantitative assessment of the benefits of specific information technologies applied to clinical studies in developing countries. Am J Trop Med Hyg (2008) 1.49
Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr Infect Dis J (2007) 1.42
Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis (2010) 1.40
Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl Trop Dis (2012) 1.39
RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol (2006) 1.38
Y box-binding protein-1 binds to the dengue virus 3'-untranslated region and mediates antiviral effects. J Biol Chem (2007) 1.37
A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med (2014) 1.37
Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J Clin Microbiol (2013) 1.35
The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology (2008) 1.31
Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. J Virol (2010) 1.31
Enhancement of dengue virus translation: role of the 3' untranslated region and the terminal 3' stem-loop domain. Virology (2004) 1.30
Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol (2013) 1.29
Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol (2005) 1.26
Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis. PLoS Negl Trop Dis (2012) 1.25
Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol (2012) 1.25
Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners. Ann N Y Acad Sci (2007) 1.25
Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency. J Gen Virol (2009) 1.25
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology (2008) 1.24
Report of an NIAID workshop on dengue animal models. Vaccine (2010) 1.23
Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol (2011) 1.22
Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One (2011) 1.20
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. PLoS Pathog (2013) 1.20
A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci (2009) 1.20
End-to-end communication in the modulation of translation by mammalian RNA viruses. Virus Res (2005) 1.20
Dengue virus modulates the unfolded protein response in a time-dependent manner. J Biol Chem (2011) 1.20
A review of biochars' potential role in the remediation, revegetation and restoration of contaminated soils. Environ Pollut (2011) 1.19
The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010. PLoS Negl Trop Dis (2013) 1.19
Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. J Virol (2006) 1.17
Unusual dengue virus 3 epidemic in Nicaragua, 2009. PLoS Negl Trop Dis (2011) 1.10
Oscillating kissing stem-loop interactions mediate 5' scanning-dependent translation by a viral 3'-cap-independent translation element. RNA (2006) 1.10
Index cluster study of dengue virus infection in Nicaragua. Am J Trop Med Hyg (2010) 1.08
Conformational changes in the solution structure of the dengue virus 5' end in the presence and absence of the 3' untranslated region. J Virol (2008) 1.07
Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis (2010) 1.05
Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol (2012) 1.05
Translation efficiency determines differences in cellular infection among dengue virus type 2 strains. Virology (2003) 1.04
Control of dengue virus translation and replication. Curr Top Microbiol Immunol (2010) 1.04
Characterization of Aedes aegypti (Diptera: Culcidae) production sites in urban Nicaragua. J Med Entomol (2007) 1.04
S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells. J Virol (2005) 1.03
Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses. Emerg Infect Dis (2016) 1.03
Severe coinfections of dengue and pandemic influenza A H1N1 viruses. Pediatr Infect Dis J (2010) 1.03
Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis (2013) 1.03
Distinct acid resistance and survival fitness displayed by Curli variants of enterohemorrhagic Escherichia coli O157:H7. Appl Environ Microbiol (2011) 1.02
Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response. Am J Trop Med Hyg (2004) 1.02
Improvement in hospital indicators after changes in dengue case management in Nicaragua. Am J Trop Med Hyg (2009) 1.02
Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology (2012) 1.01
Diagnostic accuracy of a rapid influenza test for pandemic influenza A H1N1. PLoS One (2010) 0.99
Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children. PLoS Negl Trop Dis (2012) 0.99
From construction workers to architects: developing scientific research capacity in low-income countries. PLoS Biol (2009) 0.99
Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl Trop Dis (2013) 0.98
The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication. J Virol (2010) 0.98
Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis (2008) 0.97
Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults. Infect Immun (2006) 0.97
Clustering of Mycobacterium tuberculosis cases in Acapulco: Spoligotyping and risk factors. Clin Dev Immunol (2010) 0.95
Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway. PLoS One (2012) 0.95
Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions. PLoS Negl Trop Dis (2013) 0.95
Distinct transcriptional profiles and phenotypes exhibited by Escherichia coli O157:H7 isolates related to the 2006 spinach-associated outbreak. Appl Environ Microbiol (2011) 0.94
A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology (2012) 0.94